OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 104 filers reported holding OREXIGEN THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 5.73 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $0 | – | 444 | 0.0% | 0.00% | – |
| Q4 2015 | $0 | -100.0% | 444 | -33.7% | 0.00% | – |
| Q3 2015 | $1,000 | -66.7% | 670 | 0.0% | 0.00% | – |
| Q2 2015 | $3,000 | -40.0% | 670 | -2.6% | 0.00% | – |
| Q1 2015 | $5,000 | +25.0% | 688 | 0.0% | 0.00% | – |
| Q4 2014 | $4,000 | 0.0% | 688 | -30.3% | 0.00% | – |
| Q3 2014 | $4,000 | -33.3% | 987 | 0.0% | 0.00% | – |
| Q2 2014 | $6,000 | +200.0% | 987 | +125.9% | 0.00% | – |
| Q1 2014 | $2,000 | – | 437 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 3,000,000 | $5,160,000 | 4.58% |
| Foresite Capital Management II, LLC | 6,225,049 | $10,707,000 | 3.59% |
| Scale Management, LLC | 1,312,575 | $2,258,000 | 3.46% |
| NEA Management Company, LLC | 3,709,000 | $6,379,000 | 0.41% |
| Cheyne Capital Management (UK) LLP | 413,200 | $709,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 1,189,000 | $2,045,000 | 0.31% |
| SAMLYN CAPITAL, LLC | 6,160,417 | $10,596,000 | 0.22% |
| Rock Springs Capital Management LP | 1,650,000 | $2,838,000 | 0.22% |
| Palo Alto Investors LP | 1,673,024 | $2,878,000 | 0.16% |
| GLOBEFLEX CAPITAL L P | 295,000 | $507,000 | 0.14% |